Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea

OBJECTIVE: To evaluate the efficacy of pancrealipase (PEZ) compared with placebo in the reduction of postprandial irritable bowel syndrome-diarrhoea (IBS-D). DESIGN: An intention to treat, double blind, randomised, crossover trial comparing PEZ to placebo for reduction of postprandial IBS-D. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Money, Mary E, Walkowiak, Jaroslaw, Virgilio, Chris, Talley, Nicholas J
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical Quality
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009417/
https://www.ncbi.nlm.nih.gov/pubmed/22095308
http://dx.doi.org/10.1136/fg.2010.002253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009417/
https://www.ncbi.nlm.nih.gov/pubmed/22095308
http://dx.doi.org/10.1136/fg.2010.002253

Ejemplares similares